Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01537094

The Effect of Vitamin C on Growth Hormone Secretion

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Obesity is associated with reduced growth hormone (GH) secretion. GH secretion is regulated by nutritional stimuli including fasting, insulin, glucose and free fatty acids. However, the role of micronutrients, such as vitamins, on GH secretion has not been investigated in much detail. Vitamin C levels are also reduced in obesity, and the investigators recently demonstrated a possible role for dietary vitamin C intake in the regulation of GH secretion in two preliminary retrospective studies. The investigators therefore propose a more detailed prospective physiological study to examine the effects of increasing dietary vitamin C intake on GH secretion in a physiologic, intervention study. The investigators hypothesize that increasing vitamin C concentrations in obese subjects with sub-optimal plasma vitamin C levels and reduced GH secretion will increase GH secretion.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPlacebo
DIETARY_SUPPLEMENTVitamin C 250 mg once daily
DIETARY_SUPPLEMENTVitamin C 1,000 mg once daily

Timeline

Start date
2013-12-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2012-02-23
Last updated
2013-12-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01537094. Inclusion in this directory is not an endorsement.